Advertisement

Picture Berlin Partner Berlin-Brandenburg Healthcare Industries Cluster 650x80px

Persons > All

Find below all kinds of persons.

Total search results: 7469 | Ordered by Person (ascending)
next pagenext page 1 2 3 ... 28 29 30 ... 73 74 75  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingCountry
Huber, Martin (Quantapore 201406 CEO + Founder before Ion Torrent) Chief Executive Officer (CEO) Quantapore Inc. United States (USA)
Huber, Robert (Univ Duisburg-Essen 201004 Professor ZMB before Max Planck Institute for Biochemistry, Nobel Laureate) Professor University of Duisburg-Essen Germany
Huber, Roman (Bayern Kapital 200612 Managing Director) Managing Director Bavaria (govt region) Germany
Huber, Walter (Merck 200601) n. a. Merck (DE) (Group) Germany
Huber-Saffer, Peter (Chiesi 201410 Business Development Manager at Chiesi GmbH) Business Development Manager / Strategy Manager Chiesi (Group) Germany
Huc, Jean-Francois (BioAmber 201207 CEO) Chief Executive Officer (CEO) BioAmber (Group) United States (USA)
Huchler, Roland (InnoCyte GmbH 201211 Managing Director + Founder) Managing Director InnoCyte GmbH Germany
Hudson, Paul (Sanofi 201909– CEO before Novartis Head Pharma before AstraZeneca + Schering-Plough) Chief Executive Officer (CEO) Novartis (Group) Switzerland
Huebscher, Karen (Solvias 201403– CEO before Novartis) Chief Executive Officer (CEO) Solvias (Group) Switzerland
Huels, Christoph (Protagen 200704 CEO) Chief Executive Officer (CEO) Oncimmune (Group) Germany
Huelso, Gerd (Bruker 201310 Managing Director at Bruker Daltonik GmbH) Managing Director Bruker (Group) Germany
Huenges, Martin (Maiwald Patentanwalts GmbH 200809 Munich) n. a. Maiwald Patentanwalts GmbH (Munich) Germany
Hufnagel, Lars (Bruker 201912 VP + General Manager of Luxendo Business) General Manager (management) Bruker (Group) Germany
Hufnagel, Peter (Bruker 200712 Bruker Daltonik GmbH Project Manager ProteinScape) Product Manager (personnel) Bruker (Group) Germany
Hug, Peter (Roche Pharma Partnering 200511) n. a. Roche (Group) Switzerland
Hughes, Owen (MPM Capitap 201710 Managing Director + Cullinan Oncology 201710– CEO before Intarcia + 16y at Wall Street) Managing Director MPM Capital (Group) United States (USA)
Hughes, Thomas E. (Tom) (Navitor Pharmaceuticals 202002 CEO before Zafgen 2008–2017 before Novartis) Chief Executive Officer (CEO) Navitor Pharmaceuticals Inc. United States (USA)
Huhle, Doreen (Hamburg (govt) 201208 Investment Manager at Innovationsstarter Hamburg GmbH) Investment Manager Hamburg (govt region) Germany
Huland, Edith (Immunservice GmbH 201205 Managing Director) Managing Director Immunservice GmbH Germany
Hulot, Thierry (Merck (DE) 201310– Head of Global Manufacturing + Supply at Merck Serono joined Merck 1995) President/Director/Head Business Group/Unit/Division Merck (DE) (Group) Germany
Humbey, Olivier (Accovion 201412– Country Director France) Regional manager Clinipace (Group) France
Humer, Franz B. (Roche –2014 non-exec Chairman before CEO) Board member, non-executive Roche (Group) Switzerland
Humpf, Hans-Ulrich (Univ Münster 201305 Professor) Professor University of Münster (Westfälische Wilhelms-Universität Münster) Germany
Humphries, Paul (Flextronics 201806 President High-reliability Solutions) n. a. Flextronics (d/b/a Flex) (Group) Singapore
Hundle, Bhupinder (Eucodis 200910– VP Marketing and Sales) Sales Manager / Marketing Manager Eucodis Bioscience (Group) Austria
Hung, David T. (Roivant Sciences 201704– CEO of Axovant before Medivation 201604 CEO) Chief Executive Officer (CEO) Sio Gene Therapies Inc. (Nasdaq: SIOX) United States (USA)
Hunkapiller, Michael (Mike) (Pacific Biosciences 201201–202009 CEO before Alloy Ventures + ABI President RETIRED 12/20) Chief Executive Officer (CEO) Pacific Biosciences of California Inc. (PacBio) (Nasdaq: PACB) United States (USA)
Hunkapiller, Tim (Disocovery Biosciences + Univ of Washington + Caltech) Researcher (university / research institute) Discovery Biosciences Corporation United States (USA)
Hunneyball, Ian M. n. a. Evotec (Group) Germany
Hunt, Stewart (InSphero 201602 General Manager at InSphero Inc) General Manager (management) InSphero (Group) United States (USA)
Hunter, Brian (Coral BioNet 201702 of BioNet Ventures) Managing Director Coral BioNet (Group) Germany
Huntsman, Peter R. (Huntsman 201710 CEO) n. a. Huntsman (Group) United States (USA)
Hurly, Stephen (Lava Therapeutics 202005 CEO formerly 201307 CEO of Burrill Securities LLC) Chief Executive Officer (CEO) Lava Therapeutics (Group) Netherlands
Huser, Monique (Roche 200612) n. a. Roche (Group) Switzerland
Huss, Ralf (Definiens 201302– CMO + Apceth 201110– Development Manager before Roche) Research & Development Manager Showa Denko (SDK) (Group) Germany
Husslein, Volker (GSK 201703 Head Communications at GSK Vaccines GmbH) Public Relations Manager / Investor Relations Manager GlaxoSmithKline (GSK) (Group) Germany
Hustert, Elisabeth (Scil) n. a. Coral BioNet (Group) Germany
Hutchinson, David B. A. (BioAgency 201102 Managing Director of Jomaa Pharma GmbH) Managing Director BioAgency AG Germany
Huth, Johannes (KKR 201506 Head KKR Europea, Afria + Middle East) President/Director/Head Business Group/Unit/Division Kohlberg Kravis Roberts (KKR) (Group) United States (USA)
Hutter, Bernd (Berthold Technologies 201107 Head Bioanalytical Instruments) President/Director/Head Business Group/Unit/Division Berthold Technologies (Group) Germany
Huxley, Alice (Speedel 200701 CEO) Chief Executive Officer (CEO) Novartis (Group) Switzerland
Hušman, Dejan (DenovoMatrix 201902 Managing Director) Managing Director DenovoMatrix GmbH Germany
Hübler, Karl (Eucodis Bioscience GmbH 201604 CEO) Chief Executive Officer (CEO) Eucodis Bioscience (Group) Austria
Hübner, Marc (R-Biopharm 201605 Sales Manager Germany + Austria) Sales Manager / Marketing Manager R-Biopharm (Group) Germany
Hübschmann, Hans-Joachim (CTC Analytics 201511 VP Sales Asia before Thermo Fisher) Technical Manager CTC Analytics AG Japan
Hüls, Christoph (Merck KGaA 200808– VP Operational Excellence Research before Protagen CEO) Research & Development Manager Merck (DE) (Group) Germany
Hyman, Anthony (Max Planck 201901 Group Leader at MPI-CBG Dresden + Co-Founder Dewpoint Therapeutics) Researcher (university / research institute) Max Planck Society for the Advancement of Science Germany
Hüppe, Paul (Rehberg Hüppe + Partner 201409 Patent Attorney) Patent Attorney Rehberg Hüppe + Partner Patentanwälte PartG mbB (RHP) Germany
Hüttl, Reinhard F. (acatech 201002 + Member BioÖkonomieRat) Professor acatech – Deutsche Akademie der Technikwissenschaften Germany
Hüttner, Steffen (Hölle & Hüttner 200807 Managing Director + Founder) Managing Director HB Technologies (Group) Germany
Hyvelin, Jean-Marc (Stalicla 202002 COO) Chief Operating Officer (COO) Stalicla S.A. Switzerland
Häckel, Marko (Neoplas GmbH 201206 Managing Director) Managing Director Neoplas GmbH Germany
Hämmerle, Hugo (Univ Tübingen 201204 Prof + Head of NMI) Researcher (university / research institute) University of Tübingen (Eberhard-Karls-Universität) Germany
Hänggi, Rolf (200808 before Roche VP) n. a. Roche (Group) Switzerland
Häßner, Tobias (Tecan Deutschland 200809) Sales Manager / Marketing Manager Tecan (Group) Germany
Höfer, Constance (Priaxon 201401– Chief Development Officer before Medigene + Merck KGaA + Solvay) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Priaxon AG Germany
Höfgen, Norbert (DyNAbind GmbH 201705– Managing Director (COO) + Co-Founder) Managing Director DyNAbind GmbH Germany
Höfler, Gerald (Medical Univ Graz 201308 Professor at Institute for Pathology) Professor Medical University Graz Austria
Höger, Thomas (Apogenix 200511– CEO + CFO before since 10/00 DZ Bank before BASF/Knoll) Chief Executive Officer (CEO) Apogenix GmbH Germany
Höhling, Axel (ANiMOX GmbH 200810 Managing Director) Managing Director Animox GmbH Germany
Höppner, Oliver (KeyNeurotek 200305– before interim management for biotchs + GenProfile AG + Noxxon) n. a. KeyNeurotek (Group) Germany
Iacone, Roberto (Alentis Therapeutics 202007– CEO before Versant Ventures + Roche) Chief Executive Officer (CEO) Alentis Therapeutics AG Switzerland
Iann, Max Markus (Iann 2012– Founder) Investment Manager Iann (Group) Germany
Iannone, Lucio (Bayer 201904 at Leaps by Bayer) Investment Manager Bayer (Group)
Ibrahim, Adrian (Wellcome Trust 202101 Head of Technology Transfer + Business Development at Sanger Institute) IP Manager Wellcome Trust, The United Kingdom (GB)
Icheln, Bärbel (Peptrotech GmbH 200705) n. a. PeproTech (Group) Germany
Ietsugu, Hisashi (Sysmex 200602 CEO) Chief Executive Officer (CEO) Sysmex (Group) Japan
Ikeura, Yoshinori (Axcelead 201810 CEO) Chief Executive Officer (CEO) Axcelead Drug Discovery Partners Inc. (JP) Japan
Illek, Elmar (Bruker 201407 SVP Bruker Daltonics Commercial Operations before Thermo Fisher) Chief Commercial Officer (CCO) Bruker (Group) Germany
Imhof, Axel (LMU München 201504 Professor) Professor LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) Germany
Imhof, René (Roche 200512) n. a. Roche (Group) Switzerland
Imhoff, Johannes F. (Leibniz-Gemeinschaft 201106 Professor + Head KiWiZ at IFM-GEOMAR) Professor Helmholtz-Gemeinschaft (HGF) (Group) Germany
In-Albon, Beat (Lonza 201206– COO Life Science Ingredients sector before SGS 2006–2012 before Lonza) Chief Operating Officer (COO) Lonza (Group) Switzerland
Incerti, Carlo (Forbion 201901– Operating Partner before Sanofi Genzyme + Genzyme + Biofil Srl) Partner (venture partner) Forbion Capital Partners (NL) Netherlands
Ingendoh, Arnd (Syft Technologies 202101– VP Sales Europe before Bruker VP Life Sciences MS Sales EMEA + Thermo Fisher) Sales Manager / Marketing Manager Syft Technologies (Group) Germany
Ingram, Douglas S. (Doug) (Sarepta Therapeutics 201902 CEO) Chief Executive Officer (CEO) Sarepta Therapeutics Inc. (NASDAQ: SRPT) United States (USA)
Irsfeld, Marcus (iOmx Therapeutics 201910– CFO before ProCorde GmbH + Averitas Pharma Inc) Chief Financial Officer (CFO) iOmx Therapeutics AG Germany
Irvine, Alistair (Kuros 201508 CBO) Chief Business Officer (CBO) Kuros (Group) Switzerland
Iseli, Bernhard (Tecan –200803) n. a. Tecan (Group) Switzerland
Ishida, Noriaki (Daiichi Sankyo 201512 VP Corp Communications Dept) Public Relations Manager / Investor Relations Manager Daiichi Sankyo (Group) Japan
Islam, Khalid (Gentium 200912– CEO before Arpida 199907–200805 CEO) Chief Executive Officer (CEO) Jazz Pharmaceuticals (Group) Italy
Itescu, Silviu (Mesoblast 201109 CEO) Chief Executive Officer (CEO) Mesoblast Ltd. (ASX: MSB, Nasdaq: MESO) Australia
Itin, Alexander (JSC Valenta Pharmaceuticals 201309 CEO) Chief Executive Officer (CEO) JSC Valenta Pharmaceuticals Russian Federation
Itin, Christian (Autolus 201603– CEO before Cytos 201211–201601 + Micromet 1999–2012 CEO + Co-founder + Zyomyx Inc) Chief Executive Officer (CEO) Autolus Therapeutics plc (Nasdaq: AUTL) United Kingdom (GB)
Itschert, Frank (BSSN Software GmbH 201908 Managing Director) Managing Director Merck (DE) (Group) Germany
Ittig, Simon Josef (T3 Pharmaceuticals 201909 CEO + Co-Founder) Chief Executive Officer (CEO) T3 Pharmaceuticals AG Switzerland
Ivanov, Igor (OncoLead 201012 Managing Director) Managing Director OncoLead (Group) Germany
Ivarrson, Mattias (Inositec 201610 CEO) Chief Executive Officer (CEO) Inositec AG Switzerland
Ivarsson, Carl-Johan (Qlucore AB 201209 CEO + Co-founder) Chief Executive Officer (CEO) Qlucore (Group) Sweden
Iyer, Mohan (Second Genome 201503 CBO) Chief Business Officer (CBO) Second Genome Inc. United States (USA)
Jablonka, Bernd (Sanofi 201710 Strategy + Business Development, Public Private Partnership Sanofi Germany) Business Development Manager / Strategy Manager Sanofi (Group) [since May 2011] Germany
Jackson, Oliver (Peel Hunt 201707) n. a. Peel Hunt LLP United Kingdom (GB)
Jacobi, Philipp (Quadriga Capital 201811 Managing Partner) Managing Partner (investment firm) Quadriga Capital Eigenkapitalberatung GmbH
Jacobs, Bruce (Kymera Therapeutics 201907– CFO before Westfield Capital Management + Alex Brown & Sons/Deutsche Bank) Chief Financial Officer (CFO) Kymera Therapeutics Inc. (Nasdaq: KYMR) United States (USA)
Jacobs, Elena M. (Eppendorf 201409) n. a. Eppendorf (Group) Germany
Jacotot, Frederic (Valneva 201704– General Counsel + Board Member joined 2013 before Abbott) General Counsel / Chief Legal Officer (CLO) Valneva (Group) France
Jaeger, Axel (Eppendorf 202006– CFO before Wash Tec AG + Carl Zeiss Group) Chief Financial Officer (CFO) Eppendorf (Group) Germany
Jaehnke, Torsten (Bruker 201909 Director of BioAFM) Product Manager (personnel) Bruker (Group) Germany
Jaenichen, Hans-Rainer (Vossius & Partner 200809 Munich) n. a. Vossius & Partner patent attorneys Germany
Jaffrey, Samie (Weill Cornell Medicine 201810 Prof of Pharmacology + Co-Founder of Gotham Therapeutics) Professor Cornell University United States (USA)
next pagenext page 1 2 3 ... 28 29 30 ... 73 74 75  next pagenext page



Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] No Content Marketing 650x80px

» top